Nonviral gene therapy shows potential for age-related heart diseases

Researchers at The Ohio State University Wexner Medical Center are using novel nonviral gene therapy technology to gain insight into how to treat age-related heart disease. Researchers found that adding more brown fat or increasing the level of a fat molecule, or lipokine, released by energy-burning brown fat helps preserve heart health.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup